Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the fourth quarter and full year of ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we ...

Two types of androgen deprivation therapy (ADT) had different effects on coronary atherosclerosis in a small randomized trial ...

A new study reveals that the predictive power of key inflammatory markers, such as C-reactive protein, shifts fundamentally depending on whether a patient suffers from cirrhosis or acute/chronic ...

BACKGROUND: We aimed to examine how coronary artery calcium (CAC) and its progression relate to cognitive function in midlife, an important time for cognitive aging. METHODS: We studied participants ...

Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management. The findings were presented at the ...

Researchers have developed a new artificial intelligence-based approach for detecting fatty deposits inside coronary arteries using optical coherence tomography (OCT) images. Because these lipid-rich ...

In 2018, Medicare established coverage and reimbursement for its first service using artificial intelligence (AI): computed tomography (CT) fractional flow reserve (FFRCT). FFRCT is used in ...

A new study reveals that the predictive power of key inflammatory markers, such as C-reactive protein, shifts fundamentally ...

Ischemic heart disease is the leading cause of disability and premature death worldwide. Chronic coronary syndrome (CCS), previously known as stable angina, is a progressive and chronic disease of the ...

This new peer-reviewed study from Arzani and colleagues posed the question a bit more elegantly: Can we trust MRI and CTA to give us the same anatomical story at C1? Or are they telling slightly ...